Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Liver Cirrhosis

1-methyl-3-isobutylxanthine has been researched along with Liver Cirrhosis in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Research Excerpts

ExcerptRelevanceReference
"We have combined an ex vivo model of liver fibrosis with measurement of a biochemical marker of collagen degradation in the condition medium."1.38Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model. ( Karsdal, MA; Leeming, DJ; Nielsen, MJ; Veidal, SS, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Veidal, SS1
Nielsen, MJ1
Leeming, DJ1
Karsdal, MA1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Liver Cirrhosis

ArticleYear
Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model.
    BMC research notes, 2012, Dec-18, Volume: 5, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Cell Survival; Collagen Type III; Cyclic AMP; Electrophoresis,

2012